Trial intelligence / Profile preview

Dexmedetomidine vs Ketamine vs Midazolam with Propofol in GI Endoscopy

NCT04597268Completed

Sponsor
National Cancer Institute
Start
Nov 2020
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine and ketamine in Procedural sedation (PS) (3 arms), sponsored by National Cancer Institute. Primary endpoint: Ramsy sedation score. Started Nov 2020; status: completed.

02

Drugs

dexmedetomidineketamine
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT04597268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04597268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call